Search research articles
Contact Us
Filters
Showing results (271-280 of 315) with videos related to
Page
of 32
Sort By:
Chemmedchem
|
April 9, 2026
Structure- and Ligand-Based Discovery of Novel 3-Chymotrypsin-Like Protease Nonpeptidomimetic Hits
Sabrina Silva-Mendonça, Donald Seanego, Christopher Jurisch, et al.
Plos Pathogens
|
June 24, 2020
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB
Ruslana Bryk, Shashirekha Mundhra, Xiuju Jiang, et al.
Journal of Medicinal Chemistry
|
June 17, 2021
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure-Activity Relationship, Metabolism, and Biology Triaging
Renier van der Westhuyzen, Amanda Mabhula, Paul M Njaria, et al.
Journal of Medicinal Chemistry
|
February 27, 2014
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1
Claire Le Manach, Diego Gonzàlez Cabrera, Frederic Douelle, et al.
ACS Infectious Diseases
|
December 12, 2018
Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action
Malkeet Kumar, John Okombo, Dickson Mambwe, et al.
Bioorganic & Medicinal Chemistry
|
November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization
Candice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry
|
October 7, 2025
Optimization of 2,8-Diaryl-1,5-naphthyridines as <i>Plasmodium falciparum</i> Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo Efficacy
Godwin A Dziwornu, Donald Seanego, Stephen Fienberg, et al.
ACS Infectious Diseases
|
November 3, 2022
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in <i>Mycobacterium tuberculosis</i>
Vinayak Singh, Anna E Grzegorzewicz, Stephen Fienberg, et al.
BMC Medical Education
|
October 12, 2018
The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries
Goonaseelan Pillai, Kelly Chibale, Edwin C Constable, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis
Maria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 315) with videos related to
Sort By:
Page
of 32
Chemmedchem
|
April 9, 2026
Structure- and Ligand-Based Discovery of Novel 3-Chymotrypsin-Like Protease Nonpeptidomimetic Hits
Sabrina Silva-Mendonça, Donald Seanego, Christopher Jurisch, et al.
Plos Pathogens
|
June 24, 2020
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB
Ruslana Bryk, Shashirekha Mundhra, Xiuju Jiang, et al.
Journal of Medicinal Chemistry
|
June 17, 2021
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure-Activity Relationship, Metabolism, and Biology Triaging
Renier van der Westhuyzen, Amanda Mabhula, Paul M Njaria, et al.
Journal of Medicinal Chemistry
|
February 27, 2014
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1
Claire Le Manach, Diego Gonzàlez Cabrera, Frederic Douelle, et al.
ACS Infectious Diseases
|
December 12, 2018
Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action
Malkeet Kumar, John Okombo, Dickson Mambwe, et al.
Bioorganic & Medicinal Chemistry
|
November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization
Candice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry
|
October 7, 2025
Optimization of 2,8-Diaryl-1,5-naphthyridines as <i>Plasmodium falciparum</i> Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo Efficacy
Godwin A Dziwornu, Donald Seanego, Stephen Fienberg, et al.
ACS Infectious Diseases
|
November 3, 2022
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in <i>Mycobacterium tuberculosis</i>
Vinayak Singh, Anna E Grzegorzewicz, Stephen Fienberg, et al.
BMC Medical Education
|
October 12, 2018
The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries
Goonaseelan Pillai, Kelly Chibale, Edwin C Constable, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis
Maria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.
Page
of 32